Face Forward

Understanding and managing
tuberous sclerosis complex-related Facial Angiofibroma

Patient Cases image

About

Facial
Angiofibroma

This graphic is for educational purposes only. TSC-associated Facial Angiofibroma symptoms may present differently for each person and at different points in their disease progression.

Angiofibroma icon

About 75%-85% of individuals with Tuberous Sclerosis Complex have facial angiofibroma

Angiofibromas icon

Angiofibromas on the face are benign or non-cancerous tumors made up of blood vessels and fibrous tissue which can be caused by a genetic mutation. Exposure to UV rays from the sun can also contribute to the development of facial angiofibromas

Changes in the skin icon

Changes in the skin may appear at birth for some individuals. For others, skin changes happen in childhood or adulthood.

Facial angiofibromas typically appear at early childhood and may grow in both number and size over time if left untreated

Impact quality of life icon

These growths may impact quality of life, cause appearance concerns, and may increase the risk of bleeding after minor trauma.

About Tuberous Sclerosis Complex

Complex example image icon

Tuberous Sclerosis Complex (TSC) is a rare genetic disorder with a variety of symptoms that can vary from person-to-person

Complex example image icon

Some of the organs that can be affected include the brain, heart, kidneys, lungs, and skin

Complex example image icon

While there are multiple skin manifestations, facial angiofibroma may be the most visually apparent

Complex example image icon

TSC affects nearly 2 million individuals worldwide and is usually diagnosed in children and infants

Complex example image icon

This disorder can either be passed on from the parents or arise from spontaneous mutations in someone’s DNA

Complex example image icon

TSC involves disruption in the mechanistic target of rapamycin (mTOR) pathway, which is involved in regulating cell growth and cell death

Complex example image icon

Dysfunction of the mTOR pathway leads to the unchecked growth of benign tumors in multiple organs that characterize TSC

Complex example image icon

TSC is highly variable across individuals, and can even vary among identical twins

Facial angiofibroma image

Facial angiofibroma

Rosacea

Rosacea

Acne image

Acne

This graphic is for educational purposes only. Skin conditions, including TSC-associated Facial Angiofibroma, may present differently for each person and at different points in time.

Face Forward

While facial angiofibroma may look like acne or rosacea, it is important to recognize that they are distinct conditions. Talk to your doctor about your condition and treatment options.

While symptoms may be treated effectively, there is no cure forfacial angiofibroma, and treatment may need to be continued throughout the course of the condition.

Facial angiofibroma typically do not resolve on their own, but with a better understanding of facial angiofibroma associated with TSC and the way it affects you, you and your doctor can start managing your condition.

Patient image

Not an actual patient. Individual conditions and results may vary.

Faces represent an important element of our social environment

As we look at someone, we typically examine the face starting with the area around the eyes and nose.

When we see someone with a facial defect, our eyes naturally focus on the imperfection first.

This may add to the daily emotional impact facial angiofibroma can have.

Treatment Options
for Facial Angiofibroma

Symptoms vary from person to person. If you’ve been diagnosed with facial angiofibroma, talk to your doctor about a treatment plan, including medications.

Laser therapy icon

Laser therapy

Surgery icon

Surgery

Cryotherapy icon

Cryotherapy

Gel icon

Gel

Gel icon

Cream

Physical removal may be used to treat facial angiofibroma

While surgery is not for everyone, it may be an option for people with moderate/severe facial angiofibroma. Removal can include laser therapy, surgical excision, cryotherapy, and curettage for larger tumors.

Topical therapies may be effective and well-tolerated in the treatment of facial angiofibroma.

Close surveillance and intervention are generally recommended for TSC-related skin lesions that rapidly change in size and/or number; cause functional interference, pain, or bleeding; or inhibit social interactions.

Close surveillance and intervention image

Stories in Facial Angiofibroma

Daniel

Patient
Daniel talks about the importance of a multidisciplinary approach to treating his TSC

Emilie

Patient
Emilie discusses how she overcomes the psychosocial effects of facial angiofibroma

Julie

Caregiver
Julie talks about the challenges in caring for her son’s facial angiofibroma

Kathy

Caregiver
Kathy gives her perspective as a caregiver for her son with TSC

Kelsey

Patient
Kelsey shares her story about the importance of an accurate diagnosis in individuals with TSC

Find a TSC Center icon

Find a TSC Center of Excellence or Clinic Near You

TSC Centers of Excellence (COE) and Clinics are healthcare facilities that specialize in the treatment and management of TSC, with many locations across the US. Use the map to enter your address below and find a COE or Clinic near you.